{"id":"https://openalex.org/W2394745127","doi":null,"title":"[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].","display_name":"[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].","publication_year":1992,"publication_date":"1992-10-01","ids":{"openalex":"https://openalex.org/W2394745127","mag":"2394745127","pmid":"https://pubmed.ncbi.nlm.nih.gov/1484739"},"language":"fr","primary_location":{"id":"pmid:1484739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1484739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pathologie-biologie","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111659968","display_name":"Annick Bosseray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800555055","display_name":"Centre Hospitalier Universitaire de Grenoble","ror":"https://ror.org/041rhpw39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2800555055"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A Bosseray","raw_affiliation_strings":["Clinique M\u00e9dicale et des Maladies Infectieuses, CHRU 38043, Grenoble, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinique M\u00e9dicale et des Maladies Infectieuses, CHRU 38043, Grenoble, France","institution_ids":["https://openalex.org/I2800555055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082189560","display_name":"Franck Emmanuel Nicolini","orcid":"https://orcid.org/0000-0002-3192-4199","observed_orcids":["https://orcid.org/0000-0002-3192-4199","https://orcid.org/0000-0003-3779-1996","https://orcid.org/0000-0002-3499-5080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Nicolini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J P Brion","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J P Brion","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072027146","display_name":"Mauricette Michallet","orcid":"https://orcid.org/0000-0002-7338-1081","observed_orcids":["https://orcid.org/0000-0002-7338-1081","https://orcid.org/0000-0002-3448-2832"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Michallet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068212745","display_name":"Daniel Hollard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Hollard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045050022","display_name":"J.\u2010P. Stahl","orcid":"https://orcid.org/0000-0002-0086-3557","observed_orcids":["https://orcid.org/0000-0002-0086-3557"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J P Stahl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5017573051","display_name":"M. Micoud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Micoud","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"8","first_page":"797","last_page":"804"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/empirical-antimicrobial-therapy","display_name":"empirical antimicrobial therapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/imipenem-cilastatin","display_name":"imipenem/cilastatin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.796999990940094},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.75},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.5059999823570251},{"id":"https://openalex.org/keywords/superinfection","display_name":"superinfection","score":0.8999999761581421},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.7179999947547913},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococci","display_name":"methicillin-resistant staphylococci","score":0.8709999918937683},{"id":"https://openalex.org/keywords/gram-negative-bacteria","display_name":"Gram-negative bacteria","score":0.7149999737739563},{"id":"https://openalex.org/keywords/gram-positive-bacteria","display_name":"Gram-positive bacteria","score":0.9750000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8316469192504883},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.8181592226028442},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6906901001930237},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5981049537658691},{"id":"https://openalex.org/C2777427914","wikidata":"https://www.wikidata.org/wiki/Q408529","display_name":"Amikacin","level":3,"score":0.5955883264541626},{"id":"https://openalex.org/C2776083883","wikidata":"https://www.wikidata.org/wiki/Q2601832","display_name":"Ticarcillin","level":5,"score":0.5146249532699585},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.5122784972190857},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.5081233978271484},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.49788498878479004},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.48185810446739197},{"id":"https://openalex.org/C2781255259","wikidata":"https://www.wikidata.org/wiki/Q418201","display_name":"Imipenem/cilastatin","level":5,"score":0.47861236333847046},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4418637454509735},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4016192853450775},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.378729909658432},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3227142095565796},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.12241104245185852},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.11843746900558472},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06184619665145874},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000583","descriptor_name":"Amikacin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D002442","descriptor_name":"Ceftazidime","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013982","descriptor_name":"Ticarcillin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015377","descriptor_name":"Cilastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:1484739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1484739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pathologie-biologie","raw_type":"Clinical Trial"},{"id":"mag:2394745127","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1484739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2032951174","https://openalex.org/W2465150720","https://openalex.org/W1979721068","https://openalex.org/W2002245589","https://openalex.org/W2161353443","https://openalex.org/W2416678020","https://openalex.org/W2006130113","https://openalex.org/W2059429174","https://openalex.org/W2365906519","https://openalex.org/W1964200136"],"abstract_inverted_index":{"A":[0],"three-arm":[1],"prospective":[2],"randomized":[3,78],"trial":[4],"was":[5,49],"designed":[6],"to":[7,44,60,193],"compare":[8],"the":[9,30,41,62,103,109,146,169,195],"effectiveness":[10,176],"of":[11,34,40,64,69,108,113,135,168],"single":[12],"drug":[13,54],"therapy":[14,19,25,55],"with":[15,20,26,87,90,94,182,210],"imipenemcilastatin":[16],"(IC),":[17],"two-drug":[18],"ceftazidime-vancomycin":[21],"(CV),":[22],"and":[23,59,79,92,111,130,140,158,177],"three-drug":[24],"ticarcillin-vancomycin-amikacin":[27],"(TVA)":[28],"for":[29,208],"empirical":[31],"antimicrobial":[32,170],"treatment":[33,105],"febrile":[35,74],"neutropenia":[36,75],"events.":[37],"The":[38],"objectives":[39],"study":[42],"were":[43,77,81,85,97,118,128,132,143,151],"determine":[45],"whether":[46],"IC":[47,172],"monotherapy":[48],"as":[50,52,180],"effective":[51],"combination":[53],"(CV":[56],"or":[57,184],"TVA)":[58],"assess":[61],"value":[63],"adding":[65],"vancomycin":[66],"at":[67,205],"initiation":[68],"treatment.":[70],"One":[71],"hundred":[72],"eighty-three":[73],"events":[76,150],"125":[80],"evaluable.":[82],"Success":[83],"rates":[84],"73%":[86],"IC,":[88],"67%":[89],"CV,":[91],"72%":[93],"TVA.":[95,185],"There":[96],"no":[98],"statistically":[99],"significant":[100],"differences":[101],"between":[102],"three":[104,147,159],"groups,":[106],"regardless":[107],"duration":[110],"severity":[112],"neutropenia.":[114],"Fifty-four":[115],"bacterial":[116,125],"isolates":[117],"recovered":[119,124],"from":[120],"43":[121],"patients.":[122],"Among":[123],"strains,":[126],"55%":[127],"Gram-negative":[129],"45%":[131],"Gram-positive.":[133],"Rates":[134],"bacteriologically":[136],"documented":[137],"failures":[138],"(14/33)":[139],"superinfections":[141],"(3/33)":[142],"similar":[144,175],"in":[145,203],"groups.":[148],"Adverse":[149],"rare":[152],"but":[153,191],"two":[154],"patients":[155,204],"given":[156,160,187],"CV":[157,183],"TVA":[161],"developed":[162],"severe":[163],"skin":[164],"toxicity":[165,190],"requiring":[166],"modification":[167],"regimen.":[171],"alone":[173],"showed":[174],"less":[178],"toxicity,":[179],"compared":[181],"Vancomycin":[186,198],"initially":[188],"increased":[189],"failed":[192],"improve":[194],"success":[196],"rate.":[197],"may":[199],"be":[200],"appropriate":[201],"only":[202],"high":[206],"risk":[207],"infection":[209],"methicillin-resistant":[211],"staphylococci.":[212]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}